4ZJW

RORgamma in complex with inverse agonist 16


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.5 Å
  • R-Value Free: 0.250 
  • R-Value Work: 0.190 

wwPDB Validation 3D Report Full Report


This is version 1.2 of the entry. See complete history

Literature

Discovery of biaryl carboxylamides as potent ROR gamma inverse agonists.

Chao, J.Enyedy, I.Van Vloten, K.Marcotte, D.Guertin, K.Hutchings, R.Powell, N.Jones, H.Bohnert, T.Peng, C.C.Silvian, L.Hong, V.S.Little, K.Banerjee, D.Peng, L.Taveras, A.Viney, J.L.Fontenot, J.

(2015) Bioorg.Med.Chem.Lett. 25: 2991-2997

  • DOI: 10.1016/j.bmcl.2015.05.026
  • Primary Citation of Related Structures:  

  • PubMed Abstract: 
  • RORγt is a pivotal regulator of a pro-inflammatory gene expression program implicated in the pathology of several major human immune-mediated diseases. Evidence from mouse models demonstrates that genetic or pharmacological inhibition of RORγ activit ...

    RORγt is a pivotal regulator of a pro-inflammatory gene expression program implicated in the pathology of several major human immune-mediated diseases. Evidence from mouse models demonstrates that genetic or pharmacological inhibition of RORγ activity can block the production of pathogenic cytokines, including IL-17, and convey therapeutic benefit. We have identified and developed a biaryl-carboxylamide series of RORγ inverse agonists via a structure based design approach. Co-crystal structures of compounds 16 and 48 supported the design approach and confirmed the key interactions with RORγ protein; the hydrogen bonding with His479 was key to the significant improvement in inverse agonist effect. The results have shown this is a class of potent and selective RORγ inverse agonists, with demonstrated oral bioavailability in rodents.


    Organizational Affiliation

    Immunology Research, Biogen Idec, 12 Cambridge Center, Cambridge, MA 02142, United States.,Chemical and Molecular Therapeutics, Biogen Idec, 12 Cambridge Center, Cambridge, MA 02142, United States.,Chemical and Molecular Therapeutics, Biogen Idec, 12 Cambridge Center, Cambridge, MA 02142, United States. Electronic address: jianhua.chao@gmail.com.




Macromolecules

Find similar proteins by: Sequence  |  Structure

Entity ID: 1
MoleculeChainsSequence LengthOrganismDetails
Nuclear receptor ROR-gamma
A, B
225Homo sapiensMutation(s): 0 
Gene Names: RORC (NR1F3, RORG, RZRG)
Find proteins for P51449 (Homo sapiens)
Go to Gene View: RORC
Go to UniProtKB:  P51449
Small Molecules
Ligands 1 Unique
IDChainsName / Formula / InChI Key2D Diagram3D Interactions
4P1
Query on 4P1

Download SDF File 
Download CCD File 
A
4-chloro-3-[1-(2-chloro-6-fluorobenzoyl)-1,2,3,4-tetrahydroquinolin-6-yl]-N-methylbenzamide
C24 H19 Cl2 F N2 O2
NWECRSKQCPBSPW-UHFFFAOYSA-N
 Ligand Interaction
External Ligand Annotations 
IDBinding Affinity (Sequence Identity %)
4P1EC50: 200 nM (100) BINDINGDB
4P1IC50: 100 nM (100) BINDINGDB
4P1IC50: 100 nM BINDINGMOAD
Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.5 Å
  • R-Value Free: 0.250 
  • R-Value Work: 0.190 
  • Space Group: C 1 2 1
Unit Cell:
Length (Å)Angle (°)
a = 125.586α = 90.00
b = 56.313β = 124.66
c = 79.517γ = 90.00
Software Package:
Software NamePurpose
Cootmodel building
HKL-2000data reduction
REFMACrefinement
SCALAdata scaling
PDB_EXTRACTdata extraction

Structure Validation

View Full Validation Report or Ramachandran Plots



Entry History 

Deposition Data

  • Deposited Date: 2015-04-29 
  • Released Date: 2015-06-17 
  • Deposition Author(s): Marcotte, D.J.

Revision History 

  • Version 1.0: 2015-06-17
    Type: Initial release
  • Version 1.1: 2015-06-24
    Type: Data collection
  • Version 1.2: 2017-11-01
    Type: Author supporting evidence, Database references, Derived calculations, Source and taxonomy